Study finds AI screening for OUD led to fewer hospital readmissions
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in identifying hospitalized adults at risk for opioid use disorder and referring them to inpatient addiction specialists. When compared with patients who received consultations with providers, patients screened by AI had 47% lower odds of hospital readmission within 30 days after their initial discharge, saving nearly $109,000 in care costs.
Related News Articles
Headline
The AHA has released a fact sheet explaining how artificial intelligence tools help alleviate administrative burden for providers, particularly in areas such…
Headline
The AHA’s Hospital Capacity Management Consortium will host a webinar Sept. 9 at 1 p.m. ET for capacity management and operations leaders, exploring how…
Headline
The Food and Drug Administration is seeking public feedback on a discussion paper released today on potential regulatory approaches for generative artificial…
Headline
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…
Headline
The AHA will host a webinar Aug. 19 at 1 p.m. ET on how to implement behavioral threat assessment and management programs to address workforce violence risks,…